Codexis (NASDAQ:CDXS – Get Rating) and Cyclo Therapeutics (NASDAQ:CYTH – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends. Profitability This table compares Codexis and Cyclo Therapeutics’ net margins, […]
Codexis, Inc. (NASDAQ:CDXS – Get Rating) has earned an average rating of “Buy” from the eight brokerages that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company. The average […]
Analysts expect Codexis, Inc. (NASDAQ:CDXS – Get Rating) to report sales of $38.74 million for the current quarter, according to Zacks Investment Research. Five analysts have provided estimates for Codexis’ earnings, with estimates ranging from $35.30 million to $42.30 million. Codexis reported sales of $25.45 million in the same quarter last year, which indicates a […]
Wall Street analysts expect that Codexis, Inc. (NASDAQ:CDXS – Get Rating) will report sales of $29.10 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Codexis’ earnings. The highest sales estimate is $31.70 million and the lowest is $27.58 million. Codexis posted sales of $18.03 million during […]
Codexis, Inc. (NASDAQ:CDXS – Get Rating) gapped up prior to trading on Thursday . The stock had previously closed at $20.10, but opened at $20.68. Codexis shares last traded at $20.13, with a volume of 11,329 shares changing hands. A number of equities analysts have recently weighed in on CDXS shares. Cowen started coverage on […]